HK Stock MarketDetailed Quotes

02616 CSTONE PHARMA-B

Watchlist
  • 2.820
  • -0.040-1.40%
Market Closed Apr 30 16:08 CST
3.85BMarket Cap-39.17P/E (TTM)

CSTONE PHARMA-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
Turnover
-12.21%407.21M
-2.80%254.17M
-3.64%463.84M
-0.11%261.47M
97.51%481.36M
229.48%261.77M
-76.54%243.72M
--79.45M
--1.04B
----
Operating income
-12.21%407.21M
-2.80%254.17M
-3.64%463.84M
-0.11%261.47M
97.51%481.36M
229.48%261.77M
-76.54%243.72M
79.45M
1.04B
Cost of sales
-4.70%-167.05M
23.97%-82.14M
21.40%-159.55M
-16.52%-108.04M
-90.00%-202.99M
-197.05%-92.72M
55.75%-106.83M
---31.22M
---241.42M
----
Operating expenses
-4.70%-167.05M
23.97%-82.14M
21.40%-159.55M
-16.52%-108.04M
-90.00%-202.99M
-197.05%-92.72M
55.75%-106.83M
-31.22M
-241.42M
Gross profit
-21.08%240.15M
12.12%172.03M
9.31%304.3M
-9.23%153.44M
103.36%278.38M
250.46%169.04M
-82.83%136.89M
48.23M
797.41M
Selling expenses
32.89%-133.78M
52.25%-62.77M
39.09%-199.35M
10.19%-131.45M
10.03%-327.3M
-9.56%-146.35M
-155.92%-363.79M
-455.33%-133.58M
---142.15M
---24.06M
Administrative expenses
57.42%-77.8M
47.67%-46.67M
26.64%-182.71M
33.84%-89.19M
16.31%-249.06M
12.52%-134.82M
13.11%-297.6M
6.73%-154.11M
-0.30%-342.51M
1.55%-165.23M
Research and development expenses
74.49%-134.66M
64.53%-66.25M
14.06%-527.8M
29.95%-186.77M
52.94%-614.16M
48.00%-266.63M
7.10%-1.3B
5.77%-512.75M
-0.65%-1.4B
-41.87%-544.15M
Special items of operating profit
-87.99%30.04M
-45.26%27.71M
1,293.92%250.15M
151.54%50.62M
120.30%17.95M
203.48%20.12M
30.79%-88.42M
-131.15%-19.45M
77.63%-127.75M
109.12%62.43M
Operating profit
78.61%-76.04M
111.83%24.05M
60.25%-355.42M
43.30%-203.35M
53.38%-894.2M
53.52%-358.63M
-57.24%-1.92B
-15.00%-771.65M
47.16%-1.22B
45.70%-671.01M
Financing cost
-28.33%-15.17M
-42.13%-8.35M
-39.42%-11.82M
-100.07%-5.87M
-278.10%-8.48M
-33.64%-2.94M
-69.85%-2.24M
-823.11%-2.2M
-335.64%-1.32M
-59.73%-238K
Earning before tax
75.16%-91.21M
107.50%15.7M
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
After-tax profit from continuing operations
75.16%-91.21M
107.50%15.7M
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
Earning after tax
75.16%-91.21M
107.50%15.7M
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
Profit attributable to shareholders
75.16%-91.21M
107.50%15.7M
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
Basic earnings per share
75.86%-0.07
105.88%0.01
62.34%-0.29
45.16%-0.17
53.33%-0.77
53.73%-0.31
-41.03%-1.65
-1.52%-0.67
51.05%-1.17
-148.89%-0.66
Diluted earnings per share
75.86%-0.07
105.88%0.01
62.34%-0.29
45.16%-0.17
53.33%-0.77
53.73%-0.31
-41.03%-1.65
-1.52%-0.67
51.05%-1.17
-148.89%-0.66
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020
Turnover -12.21%407.21M-2.80%254.17M-3.64%463.84M-0.11%261.47M97.51%481.36M229.48%261.77M-76.54%243.72M--79.45M--1.04B----
Operating income -12.21%407.21M-2.80%254.17M-3.64%463.84M-0.11%261.47M97.51%481.36M229.48%261.77M-76.54%243.72M79.45M1.04B
Cost of sales -4.70%-167.05M23.97%-82.14M21.40%-159.55M-16.52%-108.04M-90.00%-202.99M-197.05%-92.72M55.75%-106.83M---31.22M---241.42M----
Operating expenses -4.70%-167.05M23.97%-82.14M21.40%-159.55M-16.52%-108.04M-90.00%-202.99M-197.05%-92.72M55.75%-106.83M-31.22M-241.42M
Gross profit -21.08%240.15M12.12%172.03M9.31%304.3M-9.23%153.44M103.36%278.38M250.46%169.04M-82.83%136.89M48.23M797.41M
Selling expenses 32.89%-133.78M52.25%-62.77M39.09%-199.35M10.19%-131.45M10.03%-327.3M-9.56%-146.35M-155.92%-363.79M-455.33%-133.58M---142.15M---24.06M
Administrative expenses 57.42%-77.8M47.67%-46.67M26.64%-182.71M33.84%-89.19M16.31%-249.06M12.52%-134.82M13.11%-297.6M6.73%-154.11M-0.30%-342.51M1.55%-165.23M
Research and development expenses 74.49%-134.66M64.53%-66.25M14.06%-527.8M29.95%-186.77M52.94%-614.16M48.00%-266.63M7.10%-1.3B5.77%-512.75M-0.65%-1.4B-41.87%-544.15M
Special items of operating profit -87.99%30.04M-45.26%27.71M1,293.92%250.15M151.54%50.62M120.30%17.95M203.48%20.12M30.79%-88.42M-131.15%-19.45M77.63%-127.75M109.12%62.43M
Operating profit 78.61%-76.04M111.83%24.05M60.25%-355.42M43.30%-203.35M53.38%-894.2M53.52%-358.63M-57.24%-1.92B-15.00%-771.65M47.16%-1.22B45.70%-671.01M
Financing cost -28.33%-15.17M-42.13%-8.35M-39.42%-11.82M-100.07%-5.87M-278.10%-8.48M-33.64%-2.94M-69.85%-2.24M-823.11%-2.2M-335.64%-1.32M-59.73%-238K
Earning before tax 75.16%-91.21M107.50%15.7M59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M
After-tax profit from continuing operations 75.16%-91.21M107.50%15.7M59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M
Earning after tax 75.16%-91.21M107.50%15.7M59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M
Profit attributable to shareholders 75.16%-91.21M107.50%15.7M59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M
Basic earnings per share 75.86%-0.07105.88%0.0162.34%-0.2945.16%-0.1753.33%-0.7753.73%-0.31-41.03%-1.65-1.52%-0.6751.05%-1.17-148.89%-0.66
Diluted earnings per share 75.86%-0.07105.88%0.0162.34%-0.2945.16%-0.1753.33%-0.7753.73%-0.31-41.03%-1.65-1.52%-0.6751.05%-1.17-148.89%-0.66
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More